Analytical performance and clinical classification value of a novel sandwich immunoassay for total testosterone measurement in low-concentration and hemodialysis populations

Abstract Objectives To evaluate the analytical performance and clinical classification value of a novel sandwich testosterone immunoassay, particularly for biochemical testosterone elevation in women and deficiency in male hemodialysis patients, using LC–MS/MS as the reference method. Methods A total of 387 residual clinical serum samples were compared using Mindray TESTO, Siemens TSTII, and liquid chromatography–tandem mass spectrometry (LC–MS/MS). Among these, 226 had testosterone concentrations <1.0 ng/mL, and 133 reproductive-age women were evaluated for biochemical hyperandrogenism classification. An additional 119 hemodialysis samples (94 men, 25 women) were assessed, with the 94 men evaluated for biochemical testosterone deficiency classification. Analyses included Passing–Bablok regression, Bland–Altman analysis, and independent imprecision, linearity, and interference studies. Results The Mindray TESTO assay showed total CVs of 1.68–2.71 % and good linearity (r=0.9997). Cross-reactivity was generally low, although phenylbutazone produced biases exceeding ±10 %. Both immunoassays correlated strongly with LC–MS/MS, with Mindray TESTO showing higher correlation and narrower limits of agreement in low-concentration samples (r=0.9603 vs. 0.8920). In women of reproductive age, Mindray TESTO demonstrated higher sensitivity (88.89 vs. 11.11 %) and κ agreement (0.784 vs. 0.189) for biochemical hyperandrogenism classification. In male hemodialysis patients, it achieved higher accuracy (94.68 vs. 88.30 %) and κ agreement (0.838 vs. 0.680) for biochemical testosterone deficiency classification. The ROC AUCs did not differ significantly (0.966 vs. 0.956; p=0.2776). Conclusions The novel sandwich immunoassay showed improved agreement with LC–MS/MS at low testosterone concentrations and favorable performance in classifying biochemical testosterone elevation and deficiency.

Authors

Institutions

Publication Details

Journal
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2026-10-08
DOI
https://doi.org/10.1515/cclm-2026-0886
Primary Topic
Hormonal and reproductive studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analytical performance and clinical classification value of a novel sandwich immunoassay for total testosterone measurement in low-concentration and hemodialysis populations

Shuaiwei Han, Bingjie Shui, Jianguo Wu, Jijuan Gao et al.
Clinical Chemistry and Laboratory Medicine (CCLM)
Hormonal and reproductive studies
article

Analytical performance and clinical classification value of a novel sandwich immunoassay for total testosterone measurement in low-concentration and hemodialysis populations

Shuaiwei Han, Bingjie Shui, Jianguo Wu, Jijuan Gao, He Shi, Pengcheng Tong, Huiai Lu, Luo Yu, Huimei Wei, Minjie Liu, Huan He, Huaying Zhang
article en

Abstract

Abstract Objectives To evaluate the analytical performance and clinical classification value of a novel sandwich testosterone immunoassay, particularly for biochemical testosterone elevation in women and deficiency in male hemodialysis patients, using LC–MS/MS as the reference method. Methods A total of 387 residual clinical serum samples were compared using Mindray TESTO, Siemens TSTII, and liquid chromatography–tandem mass spectrometry (LC–MS/MS). Among these, 226 had testosterone concentrations <1.0 ng/mL, and 133 reproductive-age women were evaluated for biochemical hyperandrogenism classification. An additional 119 hemodialysis samples (94 men, 25 women) were assessed, with the 94 men evaluated for biochemical testosterone deficiency classification. Analyses included Passing–Bablok regression, Bland–Altman analysis, and independent imprecision, linearity, and interference studies. Results The Mindray TESTO assay showed total CVs of 1.68–2.71 % and good linearity (r=0.9997). Cross-reactivity was generally low, although phenylbutazone produced biases exceeding ±10 %. Both immunoassays correlated strongly with LC–MS/MS, with Mindray TESTO showing higher correlation and narrower limits of agreement in low-concentration samples (r=0.9603 vs. 0.8920). In women of reproductive age, Mindray TESTO demonstrated higher sensitivity (88.89 vs. 11.11 %) and κ agreement (0.784 vs. 0.189) for biochemical hyperandrogenism classification. In male hemodialysis patients, it achieved higher accuracy (94.68 vs. 88.30 %) and κ agreement (0.838 vs. 0.680) for biochemical testosterone deficiency classification. The ROC AUCs did not differ significantly (0.966 vs. 0.956; p=0.2776). Conclusions The novel sandwich immunoassay showed improved agreement with LC–MS/MS at low testosterone concentrations and favorable performance in classifying biochemical testosterone elevation and deficiency.

Clinical Chemistry and Laboratory Medicine (CCLM)
Zhejiang Chinese Medical University (CN), Mindray (China) (CN), Hangzhou Medical College (CN)
Openalex Percentile: Top 11%
Hormonal and reproductive studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.